Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the U…
$234.76+3.27%
报价 2026-11-06
市值
$15.07B
EV
$15.24B
PE (TTM)
–
预期 PE
–
52 周区间距高点 -10.3%
$133.19$261.62
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| JAZZJazz Pharmaceuticals plc | $15.07B | +3.3% | – | 88.2% | – | 109.6x | – | |
| ALNYAlnylam Pharmaceuticals, Inc. | $20.89B | -0.5% | +49.7% | 81.7% | 129.2x | 85.2x | 44.7x | |
| EXELExelixis, Inc. | $17.49B | +1.3% | +11.8% | 96.4% | 14.4x | 11.5x | 20.6x | |
| ASNDAscendis Pharma A/S | $16.9B | +1.3% | – | 86.3% | – | – | – | |
| BBIOBridgeBio Pharma, Inc. | $14.47B | +0.0% | +91.2% | 93.8% | – | – | – | |
| SMMTSummit Therapeutics Inc. | $13.03B | +15.1% | -82.9% | 0% | – | – | – | |
| HALOHalozyme Therapeutics, Inc. | $11.76B | -15.7% | +27.0% | 78.2% | 29.3x | 20.9x | 15.2x | |
| TECHBio-Techne Corporation | $11.43B | +0.2% | +4.6% | 65% | 99.6x | 43.2x | 42.2x | |
| KYMRKymera Therapeutics, Inc. | $11.25B | +2.8% | +48.6% | 100% | – | – | – | |
| 同行中位数 | – | – | +27.0% | 84% | 64.4x | 32.0x | 31.4x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。